How can creativity be considered in a world of compliance, strict standards, regulations and risk? In fact, the constraints that frame clinical research actually motivate a greater demand for creativity throughout the clinical trial process. As researchers design and conduct clinical trials, they continue to seek novel ways to analyze, interpret and react to ongoing data in the most efficient ways possible.
In addition to the noted constraints, clinical trial sponsors and CROs must also contend with a large degree of variability from trial to trial. CROs must support a diverse set of requirements from numerous sponsors. CROs and sponsors must support diverse therapeutic area needs while addressing the changing role of the patient in recruitment, engagement and retention activities. Data collection is becoming increasingly dynamic with the use of wearable and other mobile technologies in clinical trials.
As a result, the need for creative approaches to study design is reshaping clinical trial technologies. We have reached an inflection point. Today, researchers demand the flexibility to design and modify clinical trials based on a patient’s response to treatment. They must quickly update dosing and/or follow-up schedules, they may want to modify exclusion criteria or simply identify the need for any type of protocol change, execute it efficiently and monitor it. Modern clinical trial platforms must enable flexibility and creativity in the trial design process. If a rigid platform applies constraints on this process, or makes it difficult for research teams to develop creative solutions, the end result applies constraints on efficiency and outcomes. It is very difficult to force creative approaches into a rigid technology design.
In the past, trials were much more linear but the advent of adaptive trial design requires expertise and creativity to be simultaneously applied. In fact, creative therapeutic expertise is a strong differentiator for CROs who have the ability to conceptualize and articulate novel clinical trial designs for their sponsor clients.
Clinical trial technologies that enable creative design processes are well-positioned to serve competitive sponsors and CROs today and in the future. CROs can adapt the tools to highlight their therapeutic area expertise as well as the value they bring to the table. By enabling the creativity of the research team, CROs can also increase the likelihood of winning a trial bid.
Sponsors can also enable the creative expertise of their clinical operations resources to manage adaptive trials better. The capabilities and capacity of these teams can be transformed by flexible technologies that enable creativity. Whether a study requires unique data collection or data management requirements, platforms that enable creativity will offer better and more appropriate functionality for the needs of today and the expectations of the future.
Technology partners must seize the opportunity to enable creativity in the design and conduct of clinical trials. This will be the key that unlocks the door to new therapies. The Mednet team is already seizing this opportunity by enabling creativity on our flexible and affordable unified platform, iMednet. Our highly flexible, state-of-the-art platform is enabling greater creativity in clinical research. For sponsors, our technology is keeping up with experts to enable them to design and conduct increasingly complex clinical trials. CROs are also using these same tools to expand their service offerings and enable them to fully leverage their therapeutic expertise.
Mednet is helping scientists around the world to take novel approaches to testing the safety and efficacy of investigational drugs, biologics and medical devices – today and tomorrow.
If you would like to seize this opportunity and learn more about iMednet, please contact us to schedule a demo.